These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26067437)

  • 1. Verbal Fluency as a Rapid Screening Test for Cognitive Impairment in Early Parkinson's Disease.
    Torralva T; Laffaye T; Báez S; Gleichgerrcht E; Bruno D; Chade A; Ibañez A; Manes F; Gershanik O; Roca M
    J Neuropsychiatry Clin Neurosci; 2015; 27(3):244-7. PubMed ID: 26067437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive measures of executive dysfunction in non-demented Parkinson's disease.
    Bott NT; Johnson ET; Schuff N; Galifianakis N; Subas T; Pollock J; Pressman P; Kramer JH; Possin KL
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1430-3. PubMed ID: 25454318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding verbal fluency in healthy aging, Alzheimer's disease, and Parkinson's disease.
    McDowd J; Hoffman L; Rozek E; Lyons KE; Pahwa R; Burns J; Kemper S
    Neuropsychology; 2011 Mar; 25(2):210-25. PubMed ID: 21381827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility and limitations of Addenbrooke's Cognitive Examination-Revised for detecting mild cognitive impairment in Parkinson's disease.
    Komadina NC; Terpening Z; Huang Y; Halliday GM; Naismith SL; Lewis SJ
    Dement Geriatr Cogn Disord; 2011; 31(5):349-57. PubMed ID: 21613789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early verbal fluency decline after STN implantation: is it a cognitive microlesion effect?
    Lefaucheur R; Derrey S; Martinaud O; Wallon D; Chastan N; Gérardin E; Hannequin D; Maltête D
    J Neurol Sci; 2012 Oct; 321(1-2):96-9. PubMed ID: 22846795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of letter fluency impairment and executive dysfunction in Parkinson's disease.
    Pettit L; McCarthy M; Davenport R; Abrahams S
    J Int Neuropsychol Soc; 2013 Oct; 19(9):986-94. PubMed ID: 23953916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive deterioration rates in patients with Parkinson's disease from northeastern China.
    Luo XG; Feng Y; Liu R; Yu HM; Wang L; Wu Z; Ren Y; He ZY
    Dement Geriatr Cogn Disord; 2010; 30(1):64-70. PubMed ID: 20689285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
    Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease.
    Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
    Eur J Neurol; 2014 May; 21(5):802-7. PubMed ID: 23551560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES).
    Benito-León J; Louis ED; Posada IJ; Sánchez-Ferro Á; Trincado R; Villarejo A; Mitchell AJ; Bermejo-Pareja F
    J Neurol Sci; 2011 Nov; 310(1-2):176-82. PubMed ID: 21774946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A holistic analysis of relationships between executive function and memory in Parkinson's disease.
    Alonso Recio L; Martín P; Carvajal F; Ruiz M; Serrano JM
    J Clin Exp Neuropsychol; 2013; 35(2):147-59. PubMed ID: 23289666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosis.
    Viterbo RG; Iaffaldano P; Trojano M
    J Neurol Sci; 2013 Jul; 330(1-2):56-60. PubMed ID: 23628466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML
    Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theory of mind deficits in Parkinson's disease: a product of executive dysfunction?
    Eddy CM; Beck SR; Mitchell IJ; Praamstra P; Pall HS
    Neuropsychology; 2013 Jan; 27(1):37-47. PubMed ID: 23356595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced verbal fluency for proper names in nondemented patients with Parkinson's disease: a quantitative and qualitative analysis.
    Fine EM; Delis DC; Paul BM; Filoteo JV
    J Clin Exp Neuropsychol; 2011 Feb; 33(2):226-33. PubMed ID: 20936559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disentangling the relationship between cognitive estimation abilities and executive functions: a study on patients with Parkinson's disease.
    D'Aniello GE; Scarpina F; Albani G; Castelnuovo G; Mauro A
    Neurol Sci; 2015 Aug; 36(8):1425-9. PubMed ID: 25791888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition.
    Ricciardi L; Bloem BR; Snijders AH; Daniele A; Quaranta D; Bentivoglio AR; Fasano A
    Parkinsonism Relat Disord; 2014 Aug; 20(8):824-9. PubMed ID: 24815419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Odor identification deficits identify Parkinson's disease patients with poor cognitive performance.
    Damholdt MF; Borghammer P; Larsen L; Ostergaard K
    Mov Disord; 2011 Sep; 26(11):2045-50. PubMed ID: 21638326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.